Risk-adapted Therapy
Risk-Adapted Therapy is a treatment strategy in hematologic malignancies that belongs to the class of therapeutic decision frameworks and is distinguished by its systematic modification of chemotherapy intensity and selection based on individual patient risk profiles derived from prognostic factors such as disease biology, genetic markers, and response assessment.
258
Publications
22K
Citations
2.6K
Authors
1K
Institutions
Publications per year
2017–2026
89
258
Shaji Kumar, Joseph Mıkhael, Francis K. Buadi et al. · Mayo Clinic Proceedings · 2009 · 625 citations · Full text
Medicine, Hematology, Oncology +14
Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text
Medicine, Oncology, Pediatrics +14
1–5 of 258
2.6K
7
h-index
St. Jude Children's Research Hospital, United States
6 publications · 1.1K citations
6
h-index
5
h-index
5
h-index
5
h-index
1–5 of 2.6K
1K
Memorial Sloan Kettering Cancer Center
New York, United States
17 h-index
43 publications
2.6K citations

St. Jude Children's Research Hospital
Memphis, United States
16 h-index
112 publications
17.3K citations
Heidelberg University
Heidelberg, Germany
15 h-index
87 publications
6.4K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
15 h-index
47 publications
2.7K citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
11 h-index
36 publications
6.5K citations

University Hospital Heidelberg
Heidelberg, Germany
10 h-index
42 publications
3.5K citations
Dana-Farber Cancer Institute
Boston, United States
10 h-index
49 publications
5.9K citations
University College London
London, United Kingdom
9 h-index
55 publications
2.2K citations
1–8 of 1K
43 publications · 7K citations
37
h-index
22 publications · 3.3K citations
18
h-index
Repository · 15 publications · 746 citations
12
h-index
8 publications · 287 citations
8
h-index
7 publications · 302 citations
7
h-index
1–5